The SOLAR-RECUR trial evaluates copper Cu 64 PSMA I&T PET/CT for detecting biochemical recurrence in prostate cancer post-treatment. The trial enrolled 235 patients, focusing on detection and ...

The TENACIO Pump's smaller design and pronounced decompression mechanism improve patient interaction with the implant. Helen L. Bernie reports no challenges in implanting the AMS 700 with TENACIO Pump ...

In this video, Kara Cossis, PA-C, MPH, discusses the role of advanced practice providers (APPs) in expanding and encouraging the use of genetic testing for prostate cancer. Cossis is a physician ...

Enzalutamide plus GnRH significantly improved metastasis-free survival in nmCSPC patients with high BCR risk compared to monotherapies. The study population included patients with PSA doubling time ≤ ...

Tailor the program to available resources and staff, ensuring it fits the specific practice environment. Consistent patient-provider interactions enhance patient experience, though not always possible ...

Emory Urology's residency program is one of the largest in the U.S., offering diverse training across multiple hospital sites. Residents gain extensive clinical experience through rotations in ...

Darolutamide plus ADT significantly improved radiological progression-free survival and overall survival in mHSPC patients compared to placebo. The ARANOTE trial demonstrated benefits in secondary ...

Targeted microwave ablation using OBT fusion shows promise in treating intermediate-risk prostate cancer with precision and safety. The VIOLETTE trial enrolled 76 patients, with 37 having completed ...

"I joke that on face value, the APPs work for me, but I feel like I'm really working for them, because they basically do everything except for the surgery," says Andrew Y. Sun, MD. In this video, ...

Clinicians should reassure veterans that germline testing results will not affect their service-connected benefits during pretest counseling. Veterans exposed to agents like Agent Orange or burn pits ...